Bleakley Financial Group LLC Sells 208 Shares of Centene Co. (NYSE:CNC)

Bleakley Financial Group LLC lessened its holdings in Centene Co. (NYSE:CNC) by 2.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,114 shares of the company’s stock after selling 208 shares during the quarter. Bleakley Financial Group LLC’s holdings in Centene were worth $528,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of CNC. Operose Advisors LLC bought a new position in shares of Centene in the 3rd quarter valued at about $25,000. Coppell Advisory Solutions Corp. bought a new position in Centene during the 4th quarter worth approximately $25,000. ST Germain D J Co. Inc. bought a new position in Centene during the 2nd quarter worth approximately $26,000. OFI Invest Asset Management bought a new position in Centene during the 3rd quarter worth approximately $26,000. Finally, Headinvest LLC bought a new position in Centene during the 3rd quarter worth approximately $35,000. Institutional investors own 93.63% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently weighed in on CNC shares. UBS Group lifted their price objective on shares of Centene from $72.00 to $79.00 and gave the stock a “neutral” rating in a research note on Thursday, December 21st. Barclays began coverage on shares of Centene in a report on Wednesday, March 6th. They set an “overweight” rating and a $101.00 target price on the stock. Cantor Fitzgerald reissued an “overweight” rating and issued a $90.00 price objective on shares of Centene in a research report on Thursday, April 4th. StockNews.com lowered shares of Centene from a “strong-buy” rating to a “buy” rating in a research report on Thursday, March 28th. Finally, Truist Financial upped their price target on shares of Centene from $83.00 to $86.00 and gave the stock a “buy” rating in a research report on Thursday, December 21st. Five analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $85.08.

Insider Transactions at Centene

In other news, Director Lori Jean Robinson sold 10,000 shares of the stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $77.41, for a total value of $774,100.00. Following the completion of the transaction, the director now owns 11,455 shares of the company’s stock, valued at $886,731.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Director Lori Jean Robinson sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $77.41, for a total value of $774,100.00. Following the completion of the transaction, the director now owns 11,455 shares in the company, valued at approximately $886,731.55. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, President Kenneth J. Fasola sold 12,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $75.07, for a total transaction of $900,840.00. Following the completion of the transaction, the president now owns 235,365 shares of the company’s stock, valued at approximately $17,668,850.55. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

Centene Trading Down 1.3 %

CNC stock opened at $70.73 on Friday. Centene Co. has a 52 week low of $60.83 and a 52 week high of $81.42. The company’s 50-day simple moving average is $76.80 and its 200 day simple moving average is $74.47. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.11 and a current ratio of 1.11. The company has a market capitalization of $37.83 billion, a PE ratio of 14.41, a price-to-earnings-growth ratio of 0.89 and a beta of 0.38.

Centene (NYSE:CNC) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. Centene had a net margin of 1.75% and a return on equity of 14.26%. The business had revenue of $39.46 billion during the quarter, compared to analysts’ expectations of $36.16 billion. During the same quarter in the prior year, the business posted $0.86 earnings per share. Centene’s revenue was up 11.0% compared to the same quarter last year. As a group, sell-side analysts anticipate that Centene Co. will post 6.75 earnings per share for the current year.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.